The de-neddylation enzyme COP9 signalosome 5 (CSN5) was proposed to inhibit atherosclerosis by regulating macrophage activation through inhibiting NF-κB.63 Therefore, de-neddylation approaches may serve as a candidate strategy to decrease atherogenesis. Here, NFKB1 is linked to atherosclerosis.